There are currently 28 clinical trials in Norman, Oklahoma looking for participants to engage in research studies. Trials are conducted at various facilities, including Central Sooner Research, Lynn Institute of Norman, Cancer Care Associates - Norman and Alliance for Multispecialty Research, LLC. Whether you're a healthy volunteer looking to participate in paid medical research or seeking trials related to a specific condition, the city provides a diverse range of opportunities near you.
Fatigue and Cognitive Demand With Aging
Recruiting
This study will determine the influence of a cognitive task performed during fatiguing contractions.
Gender:
ALL
Ages:
Between 18 years and 90 years
Trial Updated:
09/05/2024
Locations: University of Oklahoma, Norman, Oklahoma
Conditions: Fatigue
Endothelial Derived Hyperpolarization Factor and Vascular Control
Recruiting
Most cardiometabolic diseases are characterized by increased muscle sympathetic nerve activity (MSNA) during rest and exercise which contributes to poor health outcomes. In healthy humans during muscle contraction, there is a blunting of skeletal muscle vascular responsiveness to increases in MSNA. However, the exact mechanisms involved are unknown although, best evidence suggests that the mechanism is endothelium derived, but nitric oxide (NO) and prostaglandin (PG) independent. Endothelium-der... Read More
Gender:
ALL
Ages:
Between 18 years and 30 years
Trial Updated:
07/19/2024
Locations: Department of Health and Exercise Science, Norman, Oklahoma
Conditions: Healthy
Intensive Glycemic Targets in Overweight and Obese Women With Gestational Diabetes
Recruiting
This is a multicenter randomized clinical trial of 828 overweight and obese individuals with gestational diabetes designed to compare standard to intensive glycemic targets.
Gender:
FEMALE
Ages:
Between 18 years and 45 years
Trial Updated:
06/09/2024
Locations: University of Oklahoma, Norman, Oklahoma
Conditions: Gestational Diabetes, Pregnancy, High Risk, Overweight and Obesity
Pharmacokinetics, Safety and Efficacy of Nemolizumab in Participants With Moderate-to-Severe Atopic Dermatitis
Recruiting
The purpose of this study is to assess the pharmacokinetics (PK), efficacy, and safety of nemolizumab in pediatric participants with moderate-to-severe atopic dermatitis (AD).
Gender:
ALL
Ages:
Between 2 years and 12 years
Trial Updated:
04/05/2023
Locations: Galderma Investigational Site #8206, Norman, Oklahoma
Conditions: Moderate-to-Severe Atopic Dermatitis